Operating Cash Flow Turning Negative and Decline in Cash Balances
First written in FY2018-Q2. 8 of 23 entries say "Mitigated", first in FY2018. Latest entry: FY2026.
- FY2026MitigatedAnnual report
「Cash provided by operating activities was ¥1,521 million, compared with an outflow of ¥1,668 million in the previous fiscal year.」
Cash flow from operating activities turned from an outflow of ¥166.8 million in the same period of the previous year to an inflow of ¥152.1 million, and cash and cash equivalents at the end of the period totaled ¥209.4 million. - FY2026-H1MitigatedAnnual report
「Cash from operating activities was an inflow of ¥87.2 million, compared with an outflow of ¥115.5 million in the same period of the previous year.」
Cash flow from operating activities turned from an outflow of ¥115.5 million in the same period of the previous year to an inflow of ¥87.2 million. With additional inflows from investing activities, cash and cash equivalents increased from ¥1,156 million at the end of the same period of the previous year to ¥3,829 million. - FY2025-H1WorsenedAnnual report
「Cash and cash equivalents (hereinafter, “funds”) at the end of the interim consolidated accounting period decreased by ¥363 million from the end of the previous fiscal year to ¥1,156 million. Cash from operating activities was an outflow of ¥115.5 million, compared with an inflow of ¥381.6 million in the same period of the previous year.」
Cash and cash equivalents decreased from ¥1,519 million to ¥1,156 million, while cash flow from operating activities turned from an inflow of ¥381.6 million in the same period of the previous year to an outflow of ¥115.5 million. Short-term borrowings increased by ¥1,797 million. - FY2024-Q3WorsenedAnnual report
「Cash and deposits 3,138,716 1,370,691」
Cash and deposits decreased from ¥3,138 million at the end of the previous fiscal year to ¥1,370 million. Cash on hand, already at a low level, has declined further. - FY2024-Q2Cash holdings remain lowAnnual report
「Cash and cash equivalents (hereinafter, “funds”) at the end of the second quarter decreased by ¥1,041 million from the end of the previous fiscal year to ¥1,892 million.」
Cash flow from operating activities turned to an inflow of ¥381.6 million, but cash and cash equivalents decreased to ¥1,892 million due to investment outflows, including the acquisition of money trusts, and financing outflows for share repurchases and dividends. - FY2023Large operating and investing cash flow deficits and decline in cash balanceAnnual report
「Cash and cash equivalents (hereinafter, "funds") at the end of the current consolidated fiscal year amounted to ¥2,934 million, compared with ¥27,438 million at the end of the previous consolidated fiscal year.」
Cash flow from operating activities was an outflow of ¥1,351.8 million, while cash flow from investing activities was an outflow of ¥2,513.1 million. Cash and cash equivalents decreased from ¥2,743.8 million to ¥293.4 million. - FY2023-Q3Decrease in cash and deposits due to deconsolidationAnnual report
「The main factors behind the decrease were declines of ¥21,713 million in other receivables, ¥8,409 million in notes and accounts receivable, ¥5,348 million in cash and deposits, and ¥1,102 million in securities.」
Cash and deposits decreased by ¥5,348 million from the end of the previous consolidated fiscal year as Cellebrite and its 13 subsidiaries changed to equity-method affiliates. - FY2023-Q2Operating and investing cash flow turn negative, but cash increases from proceeds from share salesAnnual report
「The decrease in funds from operating activities amounted to ¥9,484 million (compared with an increase of ¥1,244 million in the same period of the previous year). The decrease in funds from investing activities amounted to ¥4,974 million (compared with an increase of ¥2,560 million in the same period of the previous year). The increase in funds from financing activities amounted to ¥18,904 million (compared with a decrease of ¥5,042 million in the same period of the previous year). The main factor behind the increase was ¥22,561 million in proceeds from the sale of shares in a subsidiary without a change in the scope of consolidation.」
Cash flow from operating activities amounted to ¥9,484 million used and cash flow from investing activities to ¥4,974 million used. Meanwhile, cash and cash equivalents increased to ¥35,797 million at period-end due to financing activities, including ¥22,561 million in proceeds from the sale of shares in a subsidiary. - FY2023-Q1Sharp decline in cash and depositsAnnual report
「The main factor behind the decrease was a ¥9,888 million decline in cash and deposits.」
Cash and deposits decreased by ¥9,888 million from the end of the previous consolidated fiscal year to ¥21,790 million. Securities increased by ¥2,906 million. - FY2022MitigatedAnnual report
「With respect to cash flow growth, we place particular importance on free cash flow, defined as the sum of cash flow from operating activities and cash flow from investing activities. Free cash flow increased by ¥7,653 million in the current consolidated fiscal year.」
Cash flow from operating activities amounted to ¥3,632 million and cash flow from investing activities to ¥4,020 million, resulting in a ¥7,653 million increase in free cash flow. Cash and cash equivalents also increased by ¥6,325 million from the end of the previous fiscal year. - FY2022-Q2Operating and investing cash flow are positive, but cash balance declinesAnnual report
「Cash and cash equivalents (hereinafter, "funds") at the end of the second quarter of the current consolidated fiscal year decreased by ¥339 million from the end of the previous fiscal year to ¥20,773 million.」
While cash flow from operating activities increased by ¥1,244 million and cash flow from investing activities increased by ¥2,560 million, cash and cash equivalents decreased by ¥339 million from the end of the previous fiscal year due mainly to a ¥5,042 million decrease from financing activities. - FY2022-Q1Increase in cash balanceAnnual report
「The main factor behind the increase was a ¥1,319 million increase in cash and deposits.」
Cash and deposits increased by ¥1,319 million from the end of the previous consolidated fiscal year. No quarterly consolidated cash flow statement was prepared for the first quarter. - FY2021MitigatedAnnual report
「With respect to cash flow growth, we place particular importance on free cash flow, defined as the sum of cash flow from operating activities and cash flow from investing activities. Free cash flow increased by ¥5,200 million in the current consolidated fiscal year.」
Cash flow from operating activities turned positive at ¥6,110 million provided, and free cash flow also increased by ¥5,200 million. Cash and cash equivalents at the end of the fiscal year increased to ¥21,113 million. - FY2021-Q2Operating cash flow turns positive, but cash balance declinesAnnual report
「The increase in funds from operating activities amounted to ¥872 million (compared with a decrease of ¥1,314 million in the same period of the previous year).」
Operating cash flow shifted from ¥1,314 million used in the same period of the previous year to ¥872 million provided. However, due mainly to ¥4,617 million in cash outflows from investing activities, cash and cash equivalents decreased to ¥10,758 million at period-end. - FY2020Operating cash flow and free cash flow turn negativeAnnual report
「With respect to cash flow growth, we place particular importance on free cash flow, defined as the sum of cash flow from operating activities and cash flow from investing activities. Free cash flow decreased by ¥5,143 million in the current consolidated fiscal year.」
Operating cash flow shifted from ¥3,226 million provided in the previous fiscal year to ¥46.48 million used, and free cash flow also decreased by ¥5,143 million. Meanwhile, cash and cash equivalents stood at ¥12,700 million, due mainly to payments by non-controlling shareholders. - FY2020-Q2Operating cash flow is negative, but capital raising increases cash balanceAnnual report
「Cash and cash equivalents (hereinafter, "funds") at the end of the second quarter of the current consolidated fiscal year amounted to ¥17,944 million.」
While operating cash flow decreased by ¥1,314 million, cash and cash equivalents increased to ¥17,944 million at period-end, due mainly to ¥12,193 million in proceeds from payments by non-controlling shareholders. - FY2019-Q3Cash balance increasesAnnual report
「Cash and deposits 11,925,894 14,984,167」
Cash and deposits increased from ¥11,925 million at the end of March 2018 to ¥14,984 million at the end of December 2018, reversing the declining trend in the cash balance reported through the previous quarter. However, no cash flow statement was prepared for the third quarter. - FY2019-Q2Operating cash flow turns positive, but cash balance continues to declineAnnual report
「Funds provided by operating activities amounted to ¥864 million (compared with ¥119 million used in the same period of the previous year).」
Operating cash flow shifted from ¥119 million used in the same period of the previous year to ¥864 million provided. However, due mainly to ¥3,327 million in cash outflows from investing activities, cash and cash equivalents stood at ¥6,467 million at period-end, down ¥2,580 million from the beginning of the period. - FY2018MitigatedAnnual report
「Funds provided by operating activities amounted to ¥1,510 million (compared with ¥2,464 million provided in the previous fiscal year).」
Operating cash flow, which had been negative in the second quarter, returned to ¥1,510 million provided for the full year. Cash and cash equivalents at the end of the fiscal year stood at ¥9,047 million, down only ¥10 million from the end of the previous fiscal year. - FY2018-Q2First statedAnnual report
「Cash and cash equivalents (hereinafter, "funds") decreased by ¥119 million from the end of the previous consolidated fiscal year to ¥5,730 million, due mainly to decreases of ¥119 million from operating activities, ¥2,112 million from investing activities and ¥909 million from financing activities. Funds used in operating activities amounted to ¥100.19 million (compared with ¥1,196 million provided in the same period of the previous year).」
Operating cash flow shifted from ¥1,196 million provided in the same period of the previous year to ¥119 million used, while cash and cash equivalents decreased by ¥3,327 million from the beginning of the period.